To view this email as a web page, click here.
 
DRUG DELAY
 
Potential blockbuster arthritis drug delayed
Citing safety concerns, FDA delayed approval of a new blockbuster drug to treat rheumatoid arthritis.
Read more
 
Major EpiPen recall issued
Meridian Medical Technologies, Mylan's manufacturing partner for the EpiPen Auto-Injector, expanded a voluntary recall of the EpiPen and EpiPen Jr. epinephrine auto-injectors.
Find out why
 
Hep C drug approved for kids
FDA approved supplemental applications for 2 primary hepatitis C medications to be used in children for the first time.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.